1. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D (2003) Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45: 1136–1143
2. U.S Army Field Manual 3–9, U.S. Navy Publication P-467, U.S. Air Force Manual 355–7, “Potential Military Chemical/Biological Agents and Compounds,” Washington DC; 1990
3. Federation of American Scientists Report: “Special Weapons Primer.” October 21, 1998. Adapted from Chemical Weapons Technology Militarily Critical Technologies list (MCTL) Part II: Weapons of Mass Destruction Technologies. From: FM 8–9, NATO Handbook on the Medical Aspects of NBC Defensive of the Army, the Navy and Air Force, Washington DC; 1996
4. United Nation official reports S/16433(1984), S/17911(1986), and S/18852(1987)
5. Statistic Annals Booklet of the Janbazan Organization (2000) Clinical status of chemical warfare victims. Janbazan Organization, Health and Treatment Department